Are you up-to-date on the newest treatments for patients with advanced melanoma, the deadliest of skin cancers? Antoni Ribas and Grace Cherry will share promising medical breakthroughs in melanoma research, uncovering its biology, what makes it grow, and how it interacts with the immune system. You’ll hear about new therapies that are based on blocking the oncogene BRAF with novel BRAF and MEK inhibitors, and that unleash an antitumor immune response by blocking negative immune regulators like CTLA4 and PD-1. Learn how these novel agents differ from standard chemotherapy treatments in their mechanisms of action, toxicity profiles, and side effects, and what the nursing implications are.
This session has been planned in collaboration with the American Association of Cancer Research.
ILNAThis session qualifies for the following ONCC Individual Learning Needs Assessment (ILNA) categories.
OCN®: Scientific Basis for Practice, Treatment Modalities, Symptom Management
CBCN®: Treatment Modalities: Local and Systemic, Professional Performance, Symptom Management
AOCNP®: Cancer Treatment, Side Effect and Symptom Management
AOCNS®: Cancer Treatment, Side Effect and Symptom Management
